CONTRIBUTING TO AN AIDS-Free Generation
HIV/AIDS continues to strain health systems and contribute to increased mortality in Sub-Saharan Africa. While new HIV infections have fallen 38 percent since 2001, countries still face the challenge of diagnosing clients, and enrolling and retaining them in treatment. Within Sub-Saharan Africa, where IMA works on HIV/AIDS, only 37 percent of eligible clients are on HIV treatment.
IMA World Health began to address HIV and AIDS prevention, care, and treatment in 2004 with the launch of the PEPFAR-funded AIDSRelief Program in Tanzania. There, IMA partnered with Catholic Relief Services to build capacity for HIV/AIDS care and treatment in three dozen faith-based health facilities. IMA trained health care workers and supported sites to improve and scale up Prevention of Mother-to-Child Transmission (PMTCT), HIV testing and counseling (HTC), antiretroviral therapy (ART), and care and support services.
IMA addresses HIV/AIDS both through direct disease-specific programming, as well as through integrating HIV/AIDS interventions successfully into health care packages in South Sudan and the Democratic Republic of Congo through IMA’s health systems strengthening and sexual- and gender-based violence work. IMA is also piloting innovative HIV-linked programs, such as a Cervical Cancer screening and treatment program that helps women living with HIV address a leading opportunistic infection early and at low cost.
Today, IMA continues that work in Tanzania and more broadly in Sub-Saharan Africa through several programs that support the scale up of evidenced-based HIV prevention, care and treatment interventions.
Strengthening High Impact AIDS-Free Generation (AIDSFree) Project
IMA serves as partner on the USAID-funded global AIDSFree project. Under the leadership of JSI, IMA is helping scale-up evidenced-based HIV prevention, care, and treatment practices in high-burden HIV countries. IMA specifically helps build the capacity of faith-based networks to address HIV effectively.
DEMOCRATIC REPUBLIC OF CONGO
Ushindi Sexual and Gender-Based Violence Treatment and Prevention Project
IMA ensures female survivors of sexual- and gender-based violence (SGBV) – which has reached epidemic proportions in Eastern Congo – access holistic prevention and support services. As part of the project’s holistic approach, IMA links SGBV survivors to medical services, including access to pre-exposure prophylaxis kits and referrals for those who need HIV prevention, care, and treatment services.
Global Fund Technical Assistance Project
IMA provides technical assistance to longtime non-governmental partner SANRU to help improve its financial management, planning, M&E, and supply chain services for HIV programming. SANRU is a Global Fund Principal Recipient of both malaria and HIV/AIDS grants and recognized as one of the few local NGOs managing Global Fund grants of this size. These capacity-building efforts support improved management and implementation of critical health programs nationally.
Local Partners Excel in Comprehensive HIV & AIDS Service Delivery (LEAD)
Project LEAD is designed to increase access to HIV care, treatment, and support for people living with HIV and AIDS (PLWHA) and their families at 87 public and faith-based health facilities. IMA builds the capacity of local partner Christian Social Services Commission (CSSC) to improve HIV prevention, care, and treatment service delivery at sites in a sustainable way, assuming overall leadership of sites in an orderly transition process. The CDC-funded project’s collective work provides care to more than 83,000 people living with HIV and supports more than 50,000 clients on antiretroviral therapy (ART).
Cervical Cancer Project
HIV increases women’s risk of developing cervical cancer dramatically. Leveraging work in Project LEAD, IMA trains health care workers in visual inspection with acetic acid (VIA) screening and cryotherapy treatment, provides screening equipment and supplies, and increases community awareness on the importance of screening and early detection. The CDC-funded project has screened more than 40,000 women for cervical cancer and has treated more than 300 women with same-day treatment.